Skip to main content
Log in

Pharmacokinetics and Bioavailability of Carvedilol in Patients with Liver Cirrhosis

  • Short Communication
  • Poster Presentation
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Franz J-W, Wiewel D, Kebelhut R. Antihypertensiver Effekt einer beta-blockierend und vasodilatorisch wirkenden Substanz auf Ruhe- und Belastungsblutdruck im Vergleich zur alleinigen Beta-Rezeptorenblockade. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin 90(II): 750–752, 1984

    Google Scholar 

  • Neugebauer G, Akpan W, von Möllendorff E, Neubert P, Reiff K. Pharmacokinetics and disposition of carvedilol in humans. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): S85–S88, 1987

    PubMed  CAS  Google Scholar 

  • Reiff K. High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids. Journal of Chromatography 413: 355–362, 1987

    Article  PubMed  CAS  Google Scholar 

  • von Möllendorff E, Sponer G, Strein K, Bartech W, Müller-Beckman B, et al. Carvedilol. In Scriabine A (Ed.) New cardiovascular drugs, pp. 135–153, Raven Press, New York, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neugebauer, G., Gabor, M. & Reiff, K. Pharmacokinetics and Bioavailability of Carvedilol in Patients with Liver Cirrhosis. Drugs 36 (Suppl 6), 148–154 (1988). https://doi.org/10.2165/00003495-198800366-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800366-00026

Keywords

Navigation